Dehydroepiandrosterone, Dehydroepiandrosterone Sulfate, Obesity, Waist-Hip Ratio, and Noninsulin-Dependent Diabetes in Postmenopausal Women: The Rancho Bernardo Study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 1, 1996, Pages 59-64

  Barrett Connor, Elizabeth ^a   Ferrara, Assiamira ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE; PRASTERONE SULFATE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; DIET RESTRICTION; FEMALE; HIP; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DIABETES MELLITUS, TYPE 2; FEMALE; HIP; HUMANS; MIDDLE AGED; OBESITY; POSTMENOPAUSE;

EID: 0030025446     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.1.8550794     Document Type: Article

References (35)

1. vy/a mice by dehydroepiandrosterone. Lipids. 12:409-413.
2. Berdanier CD, Parente, Jr, JA, McIntosh MK. 1993 Is dehydroepiandrosterone an antiobesity agent? FASEB J. 7:414-419.
3. Coleman DL, Leiter EH, Applezweig N. 1984 Therapeutic effects of dehydroepi-androsterone metabolites in diabetes mutant mice (C57BL/KsJ-db/db). Endocrinology. 115:239-243.
4. Coleman DL, Leiter EH, Schwizer RW. 1982 Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes. 31:830-833.
5. Muller S, Cleary MP. 1985 Glucose metabolism in isolated adipocytes from lean and obese Zucker rats following treatment with dehydroepiandrosterone. Metabolism. 34:278-284.
6. Coleman DL, Schwizer RW, Leiter EH. 1984 Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. Diabetes. 33:26-32.
7. Tagliaferro AR, Davis JR, Truchon S, Van Hamont N. 1986 Effects of dehydroepiandrosterone acetate on metabolism, body weight and composition of male and female rats. J Nutr. 116:1977-1983.
8. Nestler JE, Barlascini CO, Clore JN, Blackard WG. 1988 Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 66:57-61.
9. Usiskin KS, Butterworth S, Clore JN, et al. 1990 Lack of effect of dehydroepiandrosterone in obese men. Int J Obes. 14:457-463.
10. Welle S, Jozefowicz R, Statt M. 1990 Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J Clin Endocrinol Metab. 71:1259-1264.
11. Mortola JF, Yen SSC. 1990 The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 71:696-704.
12. Morales AJ, Nolan JJ, Nelson JC, Yen SCC. 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 78:1360-1367.
13. Stuart CA, Nagamani M. 1990 Insulin infusion acutely augments ovarian androgen production in normal women. Fertil Steril. 54:788-792.
14. Nader S, Charles MA, Saad MF, Berkowitz AS, Bogardus G. 1993 Serum androgens in hyperinsulinemic Pima Indian and obese Caucasian women and their response to short-term insulin infusion. J Endocrinol Invest. 16:403-406.
15. Nestler JE, Clore JN, Strauss III JF, Blackard WG. 1987 The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab. 64:180-184.
16. Diamond MF, Grainger DA, Laudano AJ, Starick-Zych K, DeFronzo RA. 1991 Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women. J Clin Endocrinol Metab. 72:883-887.
17. Dunaif A, Graf M. 1989 Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin resistant women with polycystic ovary syndrome. J Clin Invest. 83:23-29.
18. Azziz R, Zacur HA, Parker, Jr, CR, Bradley, Jr, EL, Boots LR. 1991 Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women. Fertil Steril. 56:427-433.
19. Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P. 1994 Testosterone concentrations in women and men with NIDDM. Diabetes Care. 17: 405-411.
20. Desbuquois B, Aurbach GD. 1971 Use of polyethylene glycol to separate five and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab. 33:732-738.
21. Orentreich N, Brind JL, Rizer RL, Vogelman JH. 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:551-555.
22. Hopper BR, Yen SSC. 1975 Circulating concentrations of dehydroepiandrosterone and dehydroepiandrosterone sulfate during puberty. J Clin Endocrinol Metab. 40:458-461.
23. World Health Organization. 1985 Diabetes mellitus: report of a WHO study group. Geneva, Switzerland; World Health Organization; Technical Report Series, no. 727.
24. SAS Institute. 1989 SAS/STAT User's Guide. Version 6, vol. 2, ed 4. Cary, NC: SAS Institute.
25. Buyalos RP, Bradley, Jr, EL, Judd HL, Zacur HA, Azziz R. 1991 No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease. Fertil Steril. 56:1179-1182.
26. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjostrom L. 1989 Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes. 13:413-423.
27. Nieschlag E, Loriaux DL, Ruder HJ, Zucker IR, Kirschner NA, Lipsett MB. 1973 The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulfate in men. J Endocrinol. 57:123-134.
28. Barrett-Connor E, Khaw KT, Yen SSC. 1986 A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 315:1519-1524.
29. Nestler JE, Kahwash Z. 1994 Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans. J Clin Invest. 94:1484-1489.
30. Falcone T, Finegood DT, Fantus IG, Morris D. 1990 Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperglycemic women. J Clin Endocrinol Metab. 71:1653-1657.
31. Hubert GD, Schriock ED, Givens JR, Buster JE. 1991 Suppression of circulating delta 4-androstenedione and dehydroepiandrosterone sulfate during oral glucose tolerance test in normal female. J Clin Endocrinol Metab. 73:781-784.
32. Nestler JE, Usiskin KS, Barlascini CO, Welty DF, Clore JN, Blackard WG. 1989 Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms. J Clin Endocrinol Metab. 69:1040-1046.
33. Zumoff B, Bradlow HL. 1980 Sex differences in the metabolism of dehydroepiandrosterone sulfate. J Clin Endocrinol Metab. 51:334-336.
34. Zumoff B, Rosenfeld RS, Strain GW, Levin J, Fukushima DK. 1980 Sex differences in the twenty-four-hour mean plasma concentrations of dehydroepiandrosterone (DHA) and dehydroepiandrosterone sulfate (DHAS) and DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab. 51:330-333.
35. Ebeling P, Koivisto VA. 1994 Physiological importance of dehydroepiandrosterone. Lancet. 343:1479-1481.